AIM Vaccine Co., Ltd. (6660.HK)

HKD 6.09

(-1.62%)

Total Liabilities Summary of AIM Vaccine Co., Ltd.

  • AIM Vaccine Co., Ltd.'s latest annual total liabilities in 2023 was 3.37 Billion CNY , up 11.86% from previous year.
  • AIM Vaccine Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 3.57 Billion CNY , up 6.07% from previous quarter.
  • AIM Vaccine Co., Ltd. reported annual total liabilities of 3.01 Billion CNY in 2022, up 27.05% from previous year.
  • AIM Vaccine Co., Ltd. reported annual total liabilities of 2.37 Billion CNY in 2021, up 87.4% from previous year.
  • AIM Vaccine Co., Ltd. reported quarterly total liabilities of 3.37 Billion CNY for 2023 FY, up 11.86% from previous quarter.
  • AIM Vaccine Co., Ltd. reported quarterly total liabilities of 3.3 Billion CNY for 2023 Q2, up 9.67% from previous quarter.

Annual Total Liabilities Chart of AIM Vaccine Co., Ltd. (2023 - 2019)

Historical Annual Total Liabilities of AIM Vaccine Co., Ltd. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 3.37 Billion CNY 11.86%
2022 3.01 Billion CNY 27.05%
2021 2.37 Billion CNY 87.4%
2020 1.26 Billion CNY 0.0%
2019 - CNY 0.0%

Peer Total Liabilities Comparison of AIM Vaccine Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Uni-Bio Science Group Limited 152.81 Million HKD -2106.82%
CK Life Sciences Int'l., (Holdings) Inc. 7.05 Billion HKD 52.22%